TITLE

Eosinophilic oesophagitis: treatment using Montelukast

AUTHOR(S)
Sinharay, R.
PUB. DATE
August 2003
SOURCE
Gut;Aug2003, Vol. 52 Issue 8, p1228
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor published in the August 2003 issue of 'Gut' journal about the use of Montelukast as treatment for eosinophilic esophagitis.
ACCESSION #
11097213

 

Related Articles

  • Patti MG, Herbella FA. Fundoplication After Laparoscopic Heller Myotomy for Esophageal Achalasia: What Type? J Gastrointest Surg. 2010 Sept.;14(9):1453-8. Patti, Marco; Herbella, Fernando // Journal of Gastrointestinal Surgery;Nov2011, Vol. 15 Issue 11, p2121 

    No abstract available.

  • Dor Against Toupet Fundoplication After Heller Myotomy. Laparoscopic Technical Improvements and Endoscopic Support. Pontone, Stefano; Urciuoli, Paolo; Pontone, Paolo; Custureri, Filippo // Journal of Gastrointestinal Surgery;Nov2011, Vol. 15 Issue 11, p2119 

    No abstract available.

  • Antisecretory for esophagitis.  // Modern Medicine;Jun96, Vol. 64 Issue 6, p41 

    Reports on a drug called lansoprazole indicated for the treatment of erosive esophagitis, a condition characterized by gastroesophageal reflux and stomach contents which erode the mucosal lining of the esophageal tract. Lansoprazole as a proton-pump inhibitor; Recommended dosage.

  • Healed erosive esophagitis.  // Modern Medicine;Jan95, Vol. 63 Issue 1, p29 

    Reports on the use of ranitidine HCl, as Zantac from Glaxo Pharmaceutical, for the maintenance of healed erosive esophagitis. Suggested dosage; Other approved indications for the drug.

  • Medical therapy is effective--and cost-effective--for esophagitis.  // Modern Medicine;Jul97, Vol. 65 Issue 7, p57 

    Presents an abstract of the study `Choice of long-term strategy for the management of patients with severe esophagitis: A cost-utility analysis,' by G.R. Heudebert, R. Marks, C.M. Wilcox et al published in the April 1997 issue of `Gastroenterology' journal.

  • Expert panel rates GERD drugs. Liebman, Milton // Medical Marketing & Media;Dec2002, Vol. 37 Issue 12, p6 

    Examines the efficacy of over-the-counter drugs and prescription drugs for the treatment of gastroesophageal diseases in the U.S. Details on the healing actions of standard doses of proton pump inhibitors; Ability of OTC drugs to relieve heartburn and esophagitis; Use of antacids for the relief...

  • Esomeprazole: A Review of its Use in the Management of Acid-Related Disorders in the US. Scott, L.J.; Dunn, C.J.; Mallarkey, G.; Sharpe, M. // Drugs;2002, Vol. 62 Issue 7, p1091 

    Esomeprazole, the S-isomer of omeprazole, is the first proton pump inhibitor to be developed as a single optical isomer. It provides better acid control than current racemic proton pump inhibitors and has a favourable pharmacokinetic profile relative to omeprazole. In large well designed 8-week...

  • Cimetidine and metoclopramide in oesophageal reflux disease. Temple, J.G.; Bradby, G.V.H.; O'Connor, F.; Panesar, K.S.; Mulligan, T.O.; Robinson, T.J.; Ward, D.W. // British Medical Journal (Clinical Research Edition);6/11/1983, Vol. 286 Issue 6381, p1863 

    Examines the effectiveness of cimetidine and metoclopramide treatments in oesophageal reflux disease. Symptomatic and endoscopic assessment of the patients with the reflux disease; Reasons for withdrawal of the patients in the combination treatment group; Analysis of the endoscopic appearance...

  • Therapeutic Equivalence of Lansoprzole and Esomeprazole. Schoenfeld, Philip // Clinical Drug Investigation;2002, Vol. 22 Issue 6, p415 

    Comments on authors Colin Howden, E. David Ballard II and Weining Robieson's article about the therapeutic equivalence of lansoprazole and esomeprazole in the treatment of erosive esophagitis. Similarity in the healing rates of the two medications; Criteria for equivalence trials; Comparison...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics